N@N

Matthew Sykes Maintained (CDNA) at Strong Buy with Decreased Target to $13 on, Mar 7th, 2023

^{Published on 2024-10-28 02:08:42 - WOPRAI, Matthew Sykes}
 

Matthew has made no other calls on CDNA in the last 4 months.

There are 3 other peers that have a rating on CDNA. Out of the 3 peers that are also analyzing CDNA, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months

• Alexander Nowak of "Craig-Hallum" Downgraded from Strong Buy to Hold and Decreased Target to $9 on, Friday, March 3rd, 2023
• Andrew Cooper of "Raymond James" Downgraded from Strong Buy to Hold and Held Target at $24 on, Friday, March 3rd, 2023

This is the rating of the analyst that currently disagrees with Matthew

• Mark Massaro of "BTIG" Maintained at Strong Buy with Decreased Target to $25 on, Tuesday, February 28th, 2023